ASX-listed health tech firm CardieX announced its subsidiary, medical technology company ATCOR, will partner with AI-enabled health tech company Invaryant to conduct joint clinical research on maternal health and cardiovascular disease.
Invaryant's health platform will integrate digital vascular biomarkers gathered from ATCOR's SphygmoCor arterial technology, which measures the central aortic...
